1 Views The “Human Factors Engineering and Usability Testing Services Market for Medical Devices, 2020-2030” report features an extensive study of the current market landscape of companies offering human factors engineering and usability testing services for posted by Roots Analysis | Thursday, January 28, 2021 Category: Health & Medicine To order this detailed 200+ page report, please visit this link Key Inclusions A detailed assessment of the current market landscape of companies offering HFE and usability testing services based on several relevant parameters, including developer information (year of establishment, company size and location of headquarters), types of certifications obtained, types of HFE services offered in the concept phase (user research and use error risk analysis and management), design and development phase (prototype development and designing and interface development and designing), verification and validation phase (usability inspection, formative studies / usability verification, pre-validation testing / clinical trial, and summative studies / usability validation) and documentation / file compilation phase, types of other services offered (regulatory guidance, packaging and labeling, training and post market surveillance) and types of medical devices designed by the company (drug delivery devices, clinical use / care devices, diagnostic devices, therapeutic devices, home use medical Details
1 Views More than 90 companies claim to offer human factors engineering and usability testing services, catering to needs across different stages of the medical device development process, for medical devices, claims Roots Analysis posted by Roots Analysis | Thursday, January 28, 2021 Category: Health & Medicine Human factors engineering and usability testing have now become an essential part of product design across almost all industries, offering developers the chance to optimize proprietary products in alignment to the preferences of consumers To order this 200+ page report, which features 120+ figures and 100+ tables, please visit this link The USD 1 Billion (by 2030) financial opportunity within the human factors engineering and usability testing market has been analysed across the following segments: Type of tools used Generative tools Evaluative tools Type of steps involved Contextual analysis Task analysis Design analysis Formative studies Use risk analysis Known use error analysis Summative studies Regulatory document preparation’ Device class Class I medical devices Class II medical devices Class III medical devices Key geographical regions North America Europe Asia Pacific The Human Factors Engineering and Usability Testing Services Market for Medical Devices, 2020-2030 report features the following companies, which we Details
1 Views The human factors engineering and usability testing service market is projected to grow at an annualized rate of ~14%, till 2030 posted by Roots Analysis | Thursday, January 28, 2021 Category: Health & Medicine Roots Analysis has done a detailed study on Human Factors Engineering and Usability Testing Services Market for Medical Devices, 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities. To order this 200+ page report, which features 120+ figures and 100+ tables, please visit this link Key Market Insights Over time, a number of medical devices have been recalled due to various reasons; therefore, presently, HFE and usability testing is being perceived as a fundamental necessity in order to drive product development efforts Currently, more than 90 companies claim to offer human factors engineering and usability testing services, catering to needs across different stages of the medical device development process The market landscape is highly fragmented, featuring the presence of several well-established players and new entrants, many of which have varied service portfolios, focused on different types of medical devices Players involved in this domain are steadily expanding their capabilities Details
1 Views The human factors engineering and usability testing service providers market is projected to reach USD 1 Billion in 2030, predicts Roots Analysis posted by Roots Analysis | Thursday, January 28, 2021 Category: Health & Medicine Human factors engineering and usability testing have now become an essential part of product design across almost all industries, offering developers the chance to optimize proprietary products in alignment to the preferences of consumers Roots Analysis has announced the addition of “Human Factors Engineering and Usability Testing Services Market for Medical Devices, 2020-2030” report to its list of offerings The report features an extensive study on the current market landscape and future of companies offering services for HFE and usability testing for medical devices. The study includes an in-depth analysis, highlighting the capabilities of various service providers engaged in this market. Amongst other elements, the report includes: A detailed assessment of the overall landscape of companies offering human factors engineering and usability testing services for medical devices. A detailed company competitiveness analysis of HFE and usability testing service providers, taking into consideration the supplier power (based on the year of establishment of Details
1 Views The human factors engineering and usability testing services market for medical devices is projected to reach USD 1 Billion by 2030, claims Roots Analysis posted by Roots Analysis | Thursday, January 28, 2021 Category: Health & Medicine Human factors engineering and usability testing have now become an essential part of product design across almost all industries, offering developers the chance to optimize proprietary products in alignment to the preferences of consumers London Roots Analysis has announced the addition of “Human Factors Engineering and Usability Testing Services Market for Medical Devices, 2020-2030” report to its list of offerings. Given the growing regulatory stringency, there are a number of medical devices recalls reported each year. Moreover, as such solutions are gradually becoming increasingly complex, it is imperative to identify potential risks / hazards, in order to guarantee safety to end users post product launch. This has led many device developers to resort to human factors engineering and usability testing. However, the aforementioned processes require specialized resources and expertise. Therefore, outsourcing this aspect of product design and development, has become common among industry stakeholders. To order this 200+ page report, which Details
1 Views US IoT Sensor Market – Industry Analysis and Forecast (2019-2026) posted by Maximize Market Research | Thursday, January 28, 2021 Category: Health & Medicine US IoT Sensor Market is expected to grow from USD 0.95 Billion in 2019 to cross USD XX Billion by 2026, with a high double-digit CAGR between the forecast period of 2019 and 2026. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region. Maximize Market Research, a global market research firm with a dedicated team of specialists and data has carried out extensive research about the current US IoT Sensor Market outlook. The report encompasses the US IoT Sensor Market by different segments and region, providing the in-depth analysis of the overall industry ecosystem, useful for taking an informed strategic decision by the key stakeholders in the industry. Importantly, the report Details
1 Views Boost your erection and enhance your performance with generic viagra posted by Vigrapharma | Wednesday, January 27, 2021 Category: Health & Medicine It is the most popular and known drug in men that is made use for treating a certain sexual problem known by the name erectile dysfunction or male impotence. In erectile dysfunction, the men fail to sustain or get a sufficient amount of erection while having sexual intercourse. To ease the most important thing in sexual life the medicine generic viagra is used to treat the sexual disorder. The brand name of generic viagra is viagra. In comparison to the generic version, the branded version of the tablet takes more time to begin the action, and also the generic viagra cost is less expensive than the branded version erectile dysfunction pill. Men who think they are suffering from male impotence should use the anti-impotence drug to get a sufficient amount of erection while intercourse. What are the strengths that are available in the anti-impotence pill? The basic and most suggested strength is 50mg, and apart from that, the generic viagra is available in the strength of 100mg, 150mg, and 200mg. What are the ingredients and composition of the tablet? The generic viagra pill contains Details
1 Views The “China Biopharmaceutical Contract Manufacturing Market, 2020-2030” report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of biopharmaceuticals in China. posted by Roots Analysis | Wednesday, January 27, 2021 Category: Health & Medicine To order this detailed 250+ page report, please visit this link Key Inclusions A detailed review of the overall landscape of companies offering contract manufacturing services for biopharmaceuticals in China, along with information on year of establishment, company size, scale of operation (preclinical, clinical and commercial), location of headquarters, number of manufacturing facilities, as well as location of these facilities, type of business segment, type of manufacturing service(s) offered (process development and characterization, method validation and testing, analytical development, stability studies, quality assurance and control, scale-up, downstream processing, regulatory support, data analytics and reporting, and others), type of biologic(s) manufactured (peptides / proteins, antibodies, vaccines, cell therapies, gene therapies, antibody drug conjugates, vectors, biosimilars, nucleic acids and others), type of expression system(s) used (mammalian, microbial and others), type of bioreactor(s) used (single-use bioreactors and stainless steel bioreactors) and its Details
1 Views Over 35 CMOs / CDMOs in China claim to offer a variety of services related to development and manufacturing of a wide range of biotherapeutic products, claims Roots Analysis posted by Roots Analysis | Wednesday, January 27, 2021 Category: Health & Medicine Owing to benefits, such as reduced manufacturing costs, availability of cheap and skilled labor, and a supportive regulatory landscape, biopharmaceutical developers from across the globe, are increasingly outsourcing their manufacturing operations to China based CMOs. Further, in order to meet the growing demand for their services, Chinese CMOs are actively consolidating / expanding their capabilities through partnerships and / or dedicated expansion initiatives. To order this 250+ page report, which features 100+ figures and 120+ tables, please visit this link The USD 2.6 billion (by 2030) financial opportunity within the China biopharmaceutical contract manufacturing market has been analyzed across the following segments: Type of Product API FDF Type of Expression System Used Mammalian Microbial Others Scale of Operation Preclinical / Clinical Commercial Size of Manufacturer Small Mid-sized Large / Very Large Type of Biologic Antibody Vaccine Others The China Biopharma Details
1 Views The Chines biopharmaceutical contract manufacturing market is projected to grow at an annualized rate of ~13%, till 2030 posted by Roots Analysis | Wednesday, January 27, 2021 Category: Health & Medicine Roots Analysis has done a detailed study on China Biopharmaceutical Contract Manufacturing Market, 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities. To order this 250+ page report, which features 100+ figures and 120+ tables, please visit this link Key Market Insights Over 35 CMOs / CDMOs in China claim to offer a variety of services related to development and manufacturing of a wide range of biotherapeutic products Several players provide one-stop solutions and are capable of operating at various scales; the landscape includes a mix of both established players and new entrants In order to cater to the evolving needs of clients / sponsors, CMOs have established facilities across different regions of China; Eastern China, with the maximum number of sites, has emerged as a manufacturing hub With over 80 deals inked in past five years, there has been a surge in the partnership activity within this domain; majority of these collaborations were signed for the development and manufacturing of antibody-based Details
1 Views The Chinese biopharmaceutical contract manufacturing market is estimated to be worth USD 2.6 billion in 2030, predicts Roots Analysis posted by Roots Analysis | Wednesday, January 27, 2021 Category: Health & Medicine The growing biopharma industry in China has resulted in the creation of lucrative business opportunities for contract service providers; region-specific advantages have also attracted several foreign sponsors entities over the last few years Roots Analysis is pleased to announce the publication of its recent study, titled, “China Biopharmaceutical Contract Manufacturing Market, 2020-2030.” The report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of biopharmaceuticals in China. The study also features a detailed analysis of key drivers and trends related to this evolving domain. In addition to other elements, the study includes: A detailed assessment of the current market landscape of companies offering contract manufacturing services for biopharmaceuticals in China. An analysis of the partnerships that have been established in this domain, in the recent past. An analysis of the expansion initiatives undertaken by contract manufacturers in China, in order to augment their Details
1 Views The “Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019-2030” report features an extensive study of the current landscape and future outlook of the immuno-oncology biomarkers testing market (focusing particularly on TMB, MSI and posted by Roots Analysis | Wednesday, January 27, 2021 Category: Health & Medicine To order this detailed 370+ page report, please visit this link Key Inclusions A detailed analysis of ongoing, biomarker-based clinical trials initiated by big pharmaceutical companies, featuring details on immuno-oncology biomarkers and disease indications being investigated, based on trial registration year, phase of development, recruitment status, therapy design and type of cancer therapy. An analysis of the landscape of companies offering testing services for cancer biomarkers, namely TMB, MSI / MMR and TILs (including CD3+, CD4+, CD8+ and FOXP3+), based on a number of relevant parameters, such as year of establishment, size of employee base, location of headquarters, availability status of the test, biomarkers analyzed, application areas, disease indication(s) evaluated, analytical techniques utilized, turnaround time, sample input and others. An insightful 2X2 representation of the results of a detailed competitiveness analysis of various tests (segregated across different biomarker groups), taking into consideration the supplier power (size of employee base) Details
1 Views Presently, close to 50 companies are offering a variety of analytical testing solutions for the assessment of novel cancer biomarkers; majority of these tests are intended to facilitate important therapy-related decisions, claims Roots Analysis posted by Roots Analysis | Wednesday, January 27, 2021 Category: Health & Medicine Over time, pharmaceutical players have demonstrated significant interest in this domain and have launched clinical research initiatives to investigate the relevance and applications of these novel biomarkers. Several companies have already developed / are developing analytical tests for novel cancer biomarkers (TMB, MSI / MMR and TILs), intended to assist physicians in making personalized treatment decisions. To order this 370+ page report, which features 190+ figures and 180+ tables, please visit this link The USD 860 million (by 2030) financial opportunity within the cancer biomarkers market has been analyzed across the following segments: Type of test Laboratory Developed Tests (LDTs) Companion Diagnostic Tests (CDx) Type of disease indication Breast cancer Blood cancer Colon / Colorectal cancer Lung Cancer Melanoma Prostate Cancer Type of cancer biomarker TMB MSI / MMR TILs Type of analytical technique Next Generation Sequencing (NGS) Polymerase Chain Reaction (PCR) Immunohistochemistry (IHC) Others Key Details
1 Views Cancer biomarkers market for TMB, MSI / MMR and TILs is projected to grow at an annualized rate of ~18%, till 2030 posted by Roots Analysis | Wednesday, January 27, 2021 Category: Health & Medicine Roots Analysis has done a detailed study on Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019-2030, covering key aspects of the industry and identifying key future growth opportunities. To order this 370+ page report, which features 190+ figures and 180+ tables, please visit this link Key Market Insights Several novel biomarkers are presently under investigation for a variety of cancer indications; the initiatives of big pharmaceutical companies are indicative of the growing interest in this domain Presently, close to 50 companies are offering a variety of analytical testing solutions for the assessment of novel cancer biomarkers; majority of these tests are intended to facilitate important therapy-related decisions Multiple tests are currently available for specific diseases indications; next generation sequencing has emerged as a key driver, enabling high throughput results and faster turnaround times Companies involved in this domain are putting in significant efforts to develop efficient tests and differentiate their offerings, from Details
1 Views Cancer biomarkers market for TMB, MSI / MMR and TILs is estimated to be worth USD 860 million in 2030, predicts Roots Analysis posted by Roots Analysis | Wednesday, January 27, 2021 Category: Health & Medicine Advances in biotechnology have enabled the identification of several novel biomarkers, which are presently being used for a variety of purposes, including diagnosis, drug development, clinical research and to facilitate therapy-related decisions Roots Analysis is pleased to announce the publication of its recent study, titled, “Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019–2030.” The report features an extensive study of the current landscape and future outlook of the immuno-oncology biomarkers testing market (focusing particularly on TMB, MSI and TILs (CD3+, CD4+, CD8+, FOXP3+)). It provides an in-depth analysis, highlighting the capabilities of the various companies engaged in this domain. Amongst various elements, the report includes: A detailed analysis of ongoing, biomarker-based clinical trials initiated by big pharmaceutical companies. An analysis of the landscape of companies offering testing services for cancer biomarkers, namely TMB, MSI / MMR and TILs (including CD3+, CD4+, CD8+ and FOXP3+). An insightful Details
1 Views The “Neoantigen Targeted Therapies Market, 2019-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade. posted by Roots Analysis | Monday, January 25, 2021 Category: Health & Medicine To order this detailed 320+ page report, please visit this link Key Inclusions A detailed assessment of the current market landscape, providing information on drug developer(s), phase of development (marketed, clinical and preclinical / discovery stage) of lead candidates, type of molecule (small molecule and biologic), type of treatment (personalized and off-the-shelf), type of therapy (monotherapy and combination therapy), type of immunotherapy, target indication, line of treatment, and route of administration of the drugs / therapies that are being developed for the treatment of cancer. Detailed profiles of developers of neoantigen targeted therapies (shortlisted on the basis of the number of pipeline products), featuring an overview of the company, its financial information (if available), a detailed description of its product portfolio and recent collaborations. In addition, each profile includes an informed future outlook. A detailed publication analysis of close to 300 peer-reviewed, scientific articles published during the period 2015-2019 (till February), highlighting Details
1 Views Presently, over 150 neoantigen targeted therapies are being evaluated for advanced cancer indications and are designed for delivery via different routes of administration posted by Roots Analysis | Monday, January 25, 2021 Category: Health & Medicine The use of neoantigens in therapy has demonstrated the ability to elicit a strong T cell mediated immune response. Several therapy candidates are being investigated both as monotherapies and in combination with various immune checkpoint inhibitors, such as atezolizumab, durvalumab, ipilimumab, and nivolumab. Of these, certain pipeline candidates have already entered mid to late-stage (phase II and above) trials and are anticipated to enter the market over the next 5-10 years. To order this 320+ page report, which features 110+ figures and 140+ tables, please visit this link The USD 3 billion (by 2030) financial opportunity within the neoantigens market has been analyzed across the following segments: Type of target disease indication Bone cancer Colorectal cancer Gynecological cancer Non-small cell lung cancer Renal cell carcinoma Other cancers Type of neoantigens Personalized neoantigens Off-the-shelf neoantigens Type of immunotherapy Dendritic cell vaccines DNA / RNA-based vaccines Protein / peptide-based vaccines TIL-based Details
1 Views The neoantigen targeted therapies market is projected to grow at an annualized rate of 57%, till 2030 posted by Roots Analysis | Monday, January 25, 2021 Category: Health & Medicine Roots Analysis has done a detailed study on Neoantigen Targeted Therapies, 2019-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities. To order this 320+ page report, which features 110+ figures and 140+ tables, please visit this link Key Market Insights Presently, over 150 neoantigen targeted therapies are being evaluated for advanced cancer indications and are designed for delivery via different routes of administration Several molecules are in early stages of clinical development; based on delivery strategies, variety of vaccines and immunotherapies have been established for targeting personalized and shared antigens Over the years, more than 6,000 patents related to neoantigens and affiliated therapies have been granted / filed; this is indicative of the heightened pace of research in this field Both industry and academic players are contributing to the innovation, which is evident across published scientific literature focused on multiple targeted therapies for a myriad of cancer indications Several Details
1 Views The neoantigen targeted therapies market is estimated to be worth USD 3 Billion in 2030, predicts Roots Analysis posted by Roots Analysis | Monday, January 25, 2021 Category: Health & Medicine Advances in bioinformatics and genomic data analysis have enabled the identification of cancer antigens that are generally overlooked during immune surveillance; these neoantigens have been shown to possess substantial therapeutic potential London Roots Analysis is pleased to announce the publication of its recent study, titled, “Neoantigen Targeted Therapies, 2019-2030.” The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes: A detailed assessment of the current market landscape of developers engaged in the development of neoantigen targeted therapies. Detailed profiles of developers of neoantigen targeted therapies (shortlisted on the basis of the number of pipeline products). A detailed publication analysis of close to 300 peer-reviewed, scientific articles published during Details
1 Views Global Thin Film Drugs Market- Industrial Analysis and Forecast 2027, by Products, by Disease Indication and by Region. posted by Vijay Nikam | Monday, January 25, 2021 Category: Health & Medicine Global Thin Film Drugs Market was valued at USD xx million in 2018 and is expected to reach at USD xx million by 2026 at a CAGR of xx% over forecast period 2019-2026. Thin film drugs have emerged as an alternative to tablets or capsules due to its effective therapeutic results. The drugs are made of polymers that rapidly dissolve when kept in the mouth or buccal cavity, delivering the drug directly to systemic circulation in the body. The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis. Increasing demand for effective drug delivery systems, coupled with increasing research to develop newer polymeric thin films are expected to increase the demand for thin film drugs. The low manufacturing cost of thin film drugs as compared to traditional dosage forms has proven to be integral market driver in the global market. However, high costs associated with the treatment is restraining the market growth. Effective therapeutic output of the drugs when Details
